{
  "id": 18093050,
  "title": "Novo Nordisk Q3 Adj. Operating Profit Increases, Obesity Sales Up 22%; Raises 2026 Outlook",
  "url": "https://urgent.news/2026/11/04/novo-nordisk-q3-adj-operating-profit-increases-obesity-sales-up-22",
  "topic": "finance",
  "section": "Finance & Markets",
  "published": "2026-11-04T07:11:24.000Z",
  "source": {
    "name": "Nasdaq Markets",
    "slug": "nasdaq-markets",
    "url": "https://www.nasdaq.com/articles/novo-nordisk-q3-adj-operating-profit-increases-obesity-sales-22-raises-2026-outlook"
  },
  "original_language": "en",
  "account": null,
  "summary": "(RTTNews) - Novo Nordisk A/S (NVO, NOVOB.CO, NOV.DE) reported third quarter net profit of 16.74 billion Danish kroner, a decline of 16% year-over-year. Earnings per share/ ADR was 3.79 kroner, down 16%. Adjusted net profit was 25.60 billion kroner, down 12% from last year. Adjust",
  "key_points": [],
  "editors_take": null,
  "illustration": null,
  "coverage": {
    "outlets": 1,
    "also_reported_by": []
  },
  "ai_generated": true,
  "disclaimer": "Summaries, key points and the editor’s take are written by software from other outlets’ reporting and may contain errors — always check the linked original."
}